Proton Therapy for Low and Intermediate Risk Prostate Cancer
The purpose of this trial is to give a shorter course (5 Â½ weeks) of radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of radiation, without decreasing the chance of killing prostate cancer cells.
Prostate Cancer
RADIATION: Low Risk Proton Radiation|RADIATION: Intermediate Risk Proton Radiation
Acute Grade 3 (NCI CTC v4.0) or Higher Treatment-related Toxicity Rate., 6 months after the end of radiation therapy
Disease Control, 20 years after end of radiation
Low Risk - Total of 70 Gy/CGE over 28 treatments

Intermediate Risk - Total of 72.5 Gy/CGE over 29 treatments